Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
355
mi
from 43215
Rochester, NY
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
130
mi
from 43215
Beachwood, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
130
mi
from 43215
Beachwood, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
103
mi
from 43215
Canton, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
103
mi
from 43215
Canton, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
418
mi
from 43215
Jenkintown, PA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
418
mi
from 43215
Jenkintown, PA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
403
mi
from 43215
Media, PA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
403
mi
from 43215
Media, PA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
426
mi
from 43215
Columbia, SC
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
426
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
933
mi
from 43215
Arlington, TX
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
991
mi
from 43215
Houston, TX
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
341
mi
from 43215
Richmond, VA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
251
mi
from 43215
Roanoke, VA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
251
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
4451
mi
from 43215
Innsbruck,
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
4451
mi
from 43215
Innsbruck,
Click here to add this to my saved trials
A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
A Single-Center, Randomized, Investigator/Participant-Blind, Placebo-Controlled, Multiple-Ascending Dose, Semi-Sequential Adaptive Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Basimglurant Following Oral Administration in Healthy Subjects and in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1963
mi
from 43215
Garden Grove, CA
A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
A Single-Center, Randomized, Investigator/Participant-Blind, Placebo-Controlled, Multiple-Ascending Dose, Semi-Sequential Adaptive Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Basimglurant Following Oral Administration in Healthy Subjects and in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1963
mi
from 43215
Garden Grove, CA
Click here to add this to my saved trials
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated:  8/23/2016
The Medical Research Network, LLC
480
mi
from 43215
New York, NY
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated: 8/23/2016
The Medical Research Network, LLC
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes' Investigational Study Site
1636
mi
from 43215
Tucson, AZ
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes' Investigational Study Site
1636
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
922
mi
from 43215
Fort Myers, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
302
mi
from 43215
Hoffman Estates, IL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
302
mi
from 43215
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
344
mi
from 43215
Baltimore, MD
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
643
mi
from 43215
Boston, MA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
477
mi
from 43215
New York, NY
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
104
mi
from 43215
Canton, OH
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
104
mi
from 43215
Canton, OH
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
849
mi
from 43215
Oklahoma City, OK
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
525
mi
from 43215
Charleston, SC
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
525
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
2000
mi
from 43215
Bellevue, WA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
2000
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
1945
mi
from 43215
Oceanside, CA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
1945
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
1960
mi
from 43215
Santa Ana, CA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
1980
mi
from 43215
Torrence, CA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
1980
mi
from 43215
Torrence, CA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
986
mi
from 43215
Lauderhill, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
986
mi
from 43215
Lauderhill, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
773
mi
from 43215
Leesburg, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
773
mi
from 43215
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
986
mi
from 43215
North Miami, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
986
mi
from 43215
North Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
844
mi
from 43215
St. Petersburg, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
844
mi
from 43215
St. Petersburg, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
436
mi
from 43215
Atlanta, GA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
650
mi
from 43215
Haverhill, MA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
650
mi
from 43215
Haverhill, MA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
429
mi
from 43215
Berlin, NJ
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
429
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
480
mi
from 43215
Brooklyn, NY
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
480
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
69
mi
from 43215
Dayton, OH
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
69
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
416
mi
from 43215
Philadelphia, PA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
1065
mi
from 43215
Austin, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
905
mi
from 43215
Dallas, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
992
mi
from 43215
Houston, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
992
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
1138
mi
from 43215
San Antonio, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated:  11/30/2016
Massachusetts General Hospital- Depression Clinical and Research Program
643
mi
from 43215
Boston, MA
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated: 11/30/2016
Massachusetts General Hospital- Depression Clinical and Research Program
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated:  11/30/2016
Ying Wang
6745
mi
from 43215
Beijing,
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated: 11/30/2016
Ying Wang
6745
mi
from 43215
Beijing,
Click here to add this to my saved trials
Study to Treat Major Depressive Disorder (MDD) With a New Medication
A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder
Status: Enrolling
Updated:  12/20/2016
Icahn School of Medicine at Mount Sinai
mi
from 43215
New York, NY
Study to Treat Major Depressive Disorder (MDD) With a New Medication
A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder
Status: Enrolling
Updated: 12/20/2016
Icahn School of Medicine at Mount Sinai
mi
from 43215
New York, NY
Click here to add this to my saved trials
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen
Status: Enrolling
Updated:  12/22/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
537
mi
from 43215
New Haven, CT
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen
Status: Enrolling
Updated: 12/22/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials